COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2395-1443

Online ISSN:-2395-1451

CODEN : IJCEKF

Current Issue

Year 2020

Volume: 6 , Issue: 1

Article Access statistics

Viewed: 276

Emailed: 0

PDF Downloaded: 139

Indian Journal of Clinical and Experimental Ophthalmology


To evaluate the effect of intravitreal bevacizumab on intraocular pressure


Full Text PDF Share on Facebook Share on Twitter


Research Article

Author Details : Ashwini G*, Maheshwar N

Volume : 5, Issue : 3, Year : 2019

Article Page : 275-278


Suggest article by email


Abstract

Introduction: To assess intraocular pressure variation after intravitreal bevacizumab injection in patients with diabetic macular edema.
Materials and Methods: Our prospective study included 20 eyes of patients who received intravitreal injection of 0.05 ml bevacizumab as treatment option for diabetic macular edema. IOP was recorded before the injection, at 3 days, 1week, 1month and 2 months after the intravitreal injection.
Results: The mean intraocular pressure before injection was 17.28±3.04 mmHg. The mean IOP post bevacizumab at 3 days, 1 week, 1month and 2 months were 19.98± 3.23mmHg, 18.99±3.67 mmHg, 17.31±3.19 and 17.15±3.10 respectively. There was statistically significant elevation in IOP at 3 days post bevacizumab injection, which reinstated to baseline levels at final follow-up.
Conclusion: Our study indicate that intravitreal injection of bevacizumab is associated with short term IOP elevation.

Keywords: Bevacizumab, Clinically significant macular edema, Diabetic macular edema, GAT, IOP.

Doi : 10.18231/j.ijceo.2019.066

How to cite : Ashwini G, Maheshwar N, To evaluate the effect of intravitreal bevacizumab on intraocular pressure. Indian J Clin Exp Ophthalmol 2019;5(3):275-278

Copyright © 2019 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)